In our study, there was no statistical correlation of serum miR-4297 levels with methylated MGMT status for all the patients; whereas miR-4297 levels positively correlated with MGMT protein expression on glioma specimen in the female subgroup. The gene discussed is MGMT; the disease is central nervous system cancer.